Patients with severe asthma report fatigue, sleep disturbances, physical inactivity, and reduced work productivity as some of ...

The following is a summary of "Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal ...

Patients with severe asthma required fewer steroid bursts with tezepelumab-ekko, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization ...

A new report ranks Dallas as one of the most challenging places to live with seasonal allergies. A North Texas doctor ...

FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an ...

Penguins, bronzes, even hippo pagodas still sit around her house and gallery waiting for a permanent spot or, better yet, in ...

Medically reviewed by Daniel More, MD If you have allergic asthma, it’s important to have a written asthma action plan to ...

The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after the US Food and Drug Administration granted it a breakthrough designation.

Dear Annie: Nearly 13 years ago, my husband and I lost our 12-year-old son to a severe asthma attack. Since then, I have ...

AstraZeneca's first-in-class severe asthma therapy Tezspire has been approved in the EU in a new pen injector formulation suitable for administration by patients themselves. The green light for ...

Dear Annie: Nearly 13 years ago, my husband and I lost our 12-year-old son to a severe asthma attack. Since then, I have ...

Anant Ambani recently gave a major health update and shared how he has been overcoming the challenges related to his health ...